Back
The Goldman Sachs Group, Inc. Vs. Revolution Medicines, Inc. Industry Stock Comparison
Buy
75
GS
The Goldman Sachs Group, Inc.
Last Price:
$943.94
Seasonality Move:
2.27%
Buy
64
RVMD
Revolution Medicines, Inc.
Last Price:
$113.44
Seasonality Move:
-1.63%
Buy
75
The Goldman Sachs Group, Inc. (GS)
is a Buy
Is The Goldman Sachs Group, Inc. a Buy, Sell or Hold?
-
The current The Goldman Sachs Group, Inc. [GS] share price is $934.83. The Score for GS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
GS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Revolution Medicines, Inc. (RVMD)
is a Buy
Is Revolution Medicines, Inc. a Buy, Sell or Hold?
-
The current Revolution Medicines, Inc. [RVMD] share price is $107.39. The Score for RVMD is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
RVMD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GS Stock Price Chart
What is The Goldman Sachs Group, Inc.'s stock price today?
-
The The Goldman Sachs Group, Inc. share price today is $934.83Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GS is experiencing selling pressure, which indicates risk of future bearish movement.
RVMD Stock Price Chart
What is Revolution Medicines, Inc.'s stock price today?
-
The Revolution Medicines, Inc. share price today is $107.39Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RVMD is experiencing slight buying pressure.
GS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 26.41 | Buy |
| Relative Strength Index (14 RSI): | 64.38 | Buy |
| Chaikin Money Flow: | -1119648 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (863.7 - 923.46) | Buy |
| Bollinger Bands (100): | (749.26 - 863.66) | Buy |
RVMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.48 | Buy |
| Relative Strength Index (14 RSI): | 88.38 | Buy |
| Chaikin Money Flow: | 5950544 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (73.87 - 88.29) | Buy |
| Bollinger Bands (100): | (42.5 - 75.96) | Buy |
GS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 918.71 | Buy |
| 20-day SMA: | 903.37 | Buy |
| 50-day SMA: | 844.54 | Buy |
| 200-day SMA: | 715.37 | Buy |
| 8-day EMA: | 925.6 | Buy |
| 20-day EMA: | 900.88 | Buy |
| 50-day EMA: | 857.76 | Buy |
| 200-day EMA: | 742.59 | Buy |
RVMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.89 | Buy |
| 20-day SMA: | 81.66 | Buy |
| 50-day SMA: | 73.85 | Buy |
| 200-day SMA: | 48.59 | Buy |
| 8-day EMA: | 89.67 | Buy |
| 20-day EMA: | 83.17 | Buy |
| 50-day EMA: | 74.2 | Buy |
| 200-day EMA: | 54.94 | Buy |
The Goldman Sachs Group, Inc. Earnings Growth & GS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.51 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.93 per share, and an increase next year of $7.89 per share.
Revolution Medicines, Inc. Earnings Growth & RVMD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.74 per share, and an increase next year of $0.59 per share.
The Goldman Sachs Group, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Revolution Medicines, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||